So, Jodi Y. http://orcid.org/0000-0002-4395-2752
Nazaroff, Jaron http://orcid.org/0000-0002-4267-6776
Iwummadu, Chinonso V. http://orcid.org/0000-0001-9356-2237
Harris, Nicki http://orcid.org/0000-0002-5176-2932
Gorell, Emily S. http://orcid.org/0000-0002-2813-3089
Fulchand, Shivali http://orcid.org/0000-0003-2918-3931
Bailey, Irene http://orcid.org/0000-0002-8502-3775
McCarthy, Daniel http://orcid.org/0000-0001-9997-1066
Siprashvili, Zurab http://orcid.org/0000-0002-2814-4220
Marinkovich, M. Peter http://orcid.org/0000-0001-5528-8046
Tang, Jean Y. http://orcid.org/0000-0002-5510-6502
Chiou, Albert S. http://orcid.org/0000-0002-8436-0008
Clinical trials referenced in this document:
Documents that mention this clinical trial
Long-term safety and efficacy of gene-corrected autologous keratinocyte grafts for recessive dystrophic epidermolysis bullosa
https://doi.org/10.1186/s13023-022-02546-9
Funding for this research was provided by:
Abeona Therapeutics
Epidermolysis Bullosa Medical Research Foundation
Epidermolysis Bullosa Research Partnership
Dermatology Foundation Medical Career Development Award
Office of Research and Development, Palo Alto Veterans Affairs Medical Center
Article History
Received: 17 June 2022
Accepted: 4 October 2022
First Online: 17 October 2022
Declarations
:
: This study was conducted in accordance with the Declaration of Helsinki and was approved by the Stanford University Institutional Review Board. Signed informed consent was obtained from each patient prior to entering the study.
: Written informed consent including consent to publish photographs was obtained from all study participants.
: ASC, JYT, and MPM are clinical investigators for Abeona Therapeutics, Inc and Phoenix Tissue Repair. JYT is a stockholder and consultant to BridgeBio and PellePharm, Inc. ASC and JYT are also clinical investigators for Biomendics, LLC. MPM is also a clinical investigator for WINGS, Castle Creek Pharmaceuticals, and Krystal Biotech.